BPC-157, TB-500, Semax: what peptide 'cheat sheets' get wrong

What's this video probably claiming?

Based on the caption and hashtag context, @aminoclub30 appears to be running a quick-reference breakdown of popular research peptides, likely positioning each one against a specific use case: BPC-157 for recovery, TB-500 for mobility, GHK-Cu or a branded "Glow" product for skin, and Semax for cognitive function. The "Klow" reference is less standard, possibly a branded blend. Cheat-sheet content like this tends to flatten complex, context-dependent biology into tidy one-liner promises. That framing isn't automatically wrong, but it routinely skips the part where most of this evidence comes from rodent models, cell cultures, or small uncontrolled human observations, not randomized controlled trials. When a TikTok pairs a peptide name with a single function badge, viewers reasonably walk away thinking the science is more settled than it is.

What does the science actually show?

The honest answer: it depends heavily on which peptide you're asking about. BPC-157 has a reasonable preclinical signal. Sikiric et al. (2018, Current Pharmaceutical Design) documented consistent tendon and gut healing effects in rat models at doses around 10 mcg/kg, but zero peer-reviewed human RCTs exist as of this writing. TB-500, a synthetic fragment of thymosin beta-4, showed pro-angiogenic and actin-regulatory effects in cardiac tissue studies (Goldstein & Kleinman, 2015, Annals of the New York Academy of Sciences), again almost entirely in animal models. Semax, a synthetic ACTH analogue developed in Russia, has limited human trial data mostly from stroke rehabilitation contexts (Miasoedov et al., 1997, Zhurnal Nevrologii i Psikhiatrii). GHK-Cu has decent in vitro dermal fibroblast data (Pickart et al., 2015, Journal of Aging Science), but topical versus systemic delivery changes everything. The gap between "this peptide did something interesting in a mouse" and "this peptide will do that thing in your body" is not a small gap.

Where does the social media noise diverge from clinical reality?

The biggest divergence is regulatory status and delivery. In the US, most of these peptides are not FDA-approved for the conditions being implied. BPC-157 is not an approved drug. TB-500 is not an approved drug. Compounded versions exist through certain telehealth channels, but compounded does not mean clinically validated or interchangeable with a proven pharmaceutical. The FDA placed BPC-157 on its list of substances that cannot be compounded under section 503A or 503B in 2022, which is a detail most TikTok cheat sheets quietly omit. Beyond legality, dosing information shared on social platforms is often sourced from bodybuilding forums rather than pharmacokinetic studies. Semax and Selank research comes almost entirely from Soviet-era and Russian literature with limited independent replication. Presenting these compounds as a clean "cheat sheet" of functions implies a degree of clinical consensus that simply does not exist in Western peer-reviewed literature.

What should you actually know?

Peptides are not vitamins. They are biologically active signaling molecules that interact with specific receptors, and "natural" does not mean consequence-free. The preclinical science on several of these compounds is genuinely interesting, which is why researchers are pursuing it, but interesting preclinical data has a long, well-documented history of failing to translate into effective human therapies. If you're considering any peptide protocol, the questions worth asking are: Is there human trial data, not just animal data? Is the source a licensed compounding pharmacy operating under state board oversight? Has a physician reviewed your bloodwork and health history? A cheat sheet on TikTok cannot answer those questions for you, and any platform suggesting otherwise is selling convenience over accuracy.